Circulating Tumor Cells (CTC) Market Revenue Will Grow To

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Circulating Tumor Cells (CTC) Market Revenue Will Grow To $2.28 Billion By 2020: New report By Grand View Research, Inc.

San Francisco, California, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Global circulating tumor cells market is expected to reach USD 2.28 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cater to this heightened need and are therefore, expected to witness a surge in demand during the forecast period. Majority of cancer deaths are due to circulating tumor cells and an early diagnosis of the same is expected to increase survival rates. Targeted therapy in cancer has large untapped opportunities and therefore, entails extensive R&D investments aimed at new product development. However, high procedure costs and lack of commercialized products are expected to impede market growth during the forecast period.

Get More Details About Circulating Tumor Cells (CTC) Market: http://www.grandviewresearch.com/industry-ana...lls-market

Further key findings from the study suggest:

  • Tumor cell detection was the leading product segment in 2013 primarily owing to the advantages associated with therapeutic monitoring and high procedure prices. Its market is expected to reach an estimated value of over USD 250.0 million by 2020.
  • Molecular technique emerged as the largest tumor cell detection segment in 2013. This technique holds several advantages over optical tumor cell detection technique and therefore, witnesses higher usage rates. Notable advantages of molecular tumor cell detection techniques include higher sensitivity and high-throughput analysis. Moreover, the introduction of new products such as CellSearch by Janssen Pharmaceutical is expected to drive segment growth.
  • Tumor cell enrichment is also expected to witness lucrative growth over the next six years. The market is primarily driven by rapidly growing demand for prognostic technologies coupled with the presence of high patient unmet needs.
  • Immunological and immunomagnetic techniques associated with tumor cell enrichment were the largest market in 2013, accounting for a share of over 50.0%. It is the most commonly used diagnostic technique and therefore, hold high market penetration rates.
  • North America was the most revenue generating market in 2013. Presence of sophisticated healthcare infrastructure, growing prevalence of cancer and relatively larger presence of commercialized products are some factors attributing to its market position.
  • The Asia Pacific circulating tumor cells market holds lucrative future growth opportunities. High prevalence of unmet patient needs, constantly improving healthcare infrastructure and increasing healthcare expenditure levels in the emerging markets of India and China are some factors accounting for its market attractiveness.
  • Some key players of the circulating tumor cells market include AVIVA BioSciences Corporation, Silicon Biosystems S.p.A, Advanced Cell Diagnostics Inc, Celula Inc., Epic Sciences Inc., AdnaGen AG, Vitatex Inc, Rarecells Inc. and Fluxion Biosciences Inc.

For the purpose of this study, Grand View Research has segmented the global circulating tumor cells market on the basis of technology, application and region:

Global Circulating Tumor Cells Technology Outlook (Revenue, USD Million, 2012 - 2020)
    • Tumor Cell Enrichment
            • Filtration
            • Centrifugation
            • Immunological and Immunomagnetic
    • Tumor Cell Detection
            • Molecular
            • Optical
Global Circulating Tumor Cells Application Outlook (Revenue, USD Million, 2012 - 2020)
    • Prostate Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Others (pancreatic, lung, ovarian cancer)
Circulating Tumor Cells Regional Outlook (Revenue, USD Million, 2012 - 2020)
    • North America
            • U.S.
            • Canada
    • Europe
            • France
            • Germany
            • Spain
    • Asia Pacific
            • India
            • China
            • Japan
    • RoW

View complete research report on Global Circulating Tumor Cells (CTC) Market: http://www.grandviewresearch.com/industry-ana...lls-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: Grand View Research

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delta Dental Expands Free Oral Care Access in NM

Updated Category News Views 160

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 27

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
NovoTech Climbs Charts: Chambers USA Spotlight Kudos

Updated Category News Views 125

NovoTech's Moment in the Spotlight Every once in a while, a small fish manages to swim with the sharks and come out shining. NovoTech, a relative newcomer in the swarm of patent law firms, has snagged itself a spot in the inaugural Chambers USA Spotlight 2027 DC Metro Guide. Considering they're playing in the bustling intellectual property scene, this is no small...

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 122

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
Zillow Set for Major Talks at RBC Capital Markets Conference

Updated Category News Views 90

Zillow Group Prepares for a Key Presentation Turning heads again, Zillow Group, a heavyweight in real estate innovation, is gearing up for a spotlight moment. Come November 17, they're taking the stage at the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference in the Big Apple. Now, these corporate shindigs aren't always a ticker...

Continue Reading
Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Updated Category News Views 121

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

Continue Reading
Gildan Class Action: What Investors Should Know

Updated Category News Views 43

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading
Brigham Nurses Set to Strike: MGB Board Faces Scrutiny

Updated Category News Views 50

Pressure Cooker: MGB in the Hot Seat Nurses from Brigham and Women's Hospital aren't backing down, folks. They're feverishly preparing for a full-scale strike, set to kick off on November 12, if Mass General Brigham (MGB) doesn't budge on contract negotiations. Since today is November 6, they've got just a few days to find common ground. Let me tell you, the stakes...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 60

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Capitol Securities Adds Financial Veterans to Team

Updated Category News Views 116

Big Moves in Sarasota: Capitol Securities' New Additions In a world where every Wall Street whisper can send ripples through financial markets, Capitol Securities Management's move to bring on Joe Malave and Katy Carrigan is anything but a minor footnote. You'd think, by now, we'd be numb to industry shifts, but when a pro like Malave, with his 30 years of financial...

Continue Reading

Top 5 Most Recently Viewed Articles

Current Market Sentiment Surrounding Ameriprise Financial Inc.

Updated Category News Views 210

Current Overview of Ameriprise Financial Inc's Market Position Ameriprise Financial Inc's (NYSE: AMP) short interest has demonstrated significant changes recently. The short interest, or the percentage of shares sold short relative to total float, has decreased by 8.0% since the last report. Currently, there are 2.20 million shares sold short, representing 2.76% of the...

Continue Reading
Analyzing McKesson's Advantage in the Options Market Today

Updated Category News Views 132

Investors' Optimism Towards McKesson There's a palpable sense of bullish sentiment surrounding McKesson, a key player in the pharmaceutical wholesale industry. Known by its stock ticker MCK, the company has captured the attention of affluent investors who are making notable moves in the options market. It’s essential for retail traders to keep an eye on these...

Continue Reading
Tuya Inc. Delivers Impressive Q2 2025 Financial Results

Updated Category News Views 329

Tuya Inc. Reports Strong Financial Performance for Q2 2025 Tuya Inc. (NYSE: TUYA), a prominent AI-driven cloud platform service provider, has released its second-quarter financial results for the year, reflecting a firm commitment to innovation and robust market strategies. This latest report outlines a remarkable growth trajectory as the company adapts to shifting market...

Continue Reading
Understanding Winter's Toll on Your Pet's Health and Comfort

Updated Category News Views 151

How Winter Weather Affects Our Beloved Pets As the chill of winter descends, pet owners must consider the effects this season can have on their furry friends, particularly older pets. As we layer ourselves in cozy sweaters, our pets may struggle with discomfort and pain, especially in their joints. It’s essential to stay aware of these changes to ensure our pets remain...

Continue Reading
Celebrating Creative Achievements in Psychoanalysis: The Sigourney Award

Updated Category News Views 144

The Sigourney Award-2025 Recognizes Innovative Contributions The Sigourney Award-2025 has celebrated four outstanding recipients for their creative contributions that expand psychoanalytic thought on a global scale. This prestigious award is designed to recognize significant work that showcases the advancements and applications of psychoanalysis. The announcement was made...

Continue Reading